탭메뉴
| 번호 | 구분 | 제목 |
|---|---|---|
| 320 | (국외)SCI | Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy Seung Up |
| 319 | (국외)SCI | Anti-refux mucosectomy using a cap?assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study |
| 318 | (국외)SCIE | Antioxidant therapy in chronic pancreatitis?promises and pitfalls |
| 317 | (국외)SCIE | Validation of the liver disease quality of life instrument 1.0 in patients with chronic hepatitis B: a prospective study |
| 316 | (국외)SCI | Periodontitis is associated with an increased risk for proximal colorectal neoplasms |
| 315 | (국외)SCI | Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidaseto- platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy |
| 314 | (국외)SCI | Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization |
| 313 | (국외)SCI | Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein?Barr Virus-Infected Gastric Cancer Cells |
| 312 | (국외)SCI | A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea. |
| 311 | (국외)SCI | Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. |
Copyright ⓒ chamc, All rights reserved.
